A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

May 7, 2024

Primary Completion Date

April 22, 2025

Study Completion Date

September 26, 2025

Conditions

Ventral HerniaAbdominal Hernia

Interventions

DRUG

BOTOX Dose A

Injection; intramuscular

DRUG

Placebo for BOTOX

Placebo

DRUG

BOTOX Dose B

Injection; intramuscular

DRUG

BOTOX Dose C

Injection; intramuscular

Trial Locations (2)

NYU Langone Hospital - Long Island /ID# 251280, Mineola

Atrium Health Carolinas Medical Center /ID# 247711, Charlotte